Days after Glenmark Pharmaceuticals launched its anti-viral drug to treat coronavirus patients, the company's shares surged 40 per cent to Rs 572.7 on Monday in the intra-day trade on the BSE.

Glenmark's shares rise up to 40% following launch of potential coronavirus drug

glenmark-stock

Glenmark Stock, News on Glenmark Stock, stories on Glenmark Stock, articles on Glenmark Stock, Glenmark Stock stories at Wion, Glenmark Stock news, Glenmark Stock latest news

glenmark stock

Glenmark's shares rise up to 40% following launch of potential coronavirus drug